• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Certain cancer therapy innovations not associated with decreasing mortality

byAndrew Bishara
August 30, 2013
in Chronic Disease, Oncology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD Normal Mammogram

1. New technological developments for five different cancers found not to impact mortality trends favorably 

2. For cancers observed in this study, mortality trends decreased from 1970-2005 – most likely associated with overall improvements in healthcare 

Evidence Rating Level: 2 (Good)

Study Rundown: With increasing healthcare costs associated with new technological diagnostic and therapeutic developments, many in government, as well as public health, are interested in determining the effects of these new technologies. This study sought to identify whether new innovations in cancer treatment have significantly improved mortality trends in seven European countries after their introduction between the years of 1970 and 2005.

Looking at treatment innovations developed for breast cancer, cervical cancer, testicular cancer, Hodgkin’s disease, and leukemia, researchers used joinpoint models to compare mortality trends before and after the introduction of the treatment and found there to be no significant changes in mortality associated with the introduction of the technology. In most cases, mortality trends were already decreasing and continued to decrease after the introduction of the technology. This observation led to the conclusion that overall improvements in healthcare during this time period were contributing to decreasing mortality. This study is large in scale across seven countries and over three decades, however researchers were unable to control for biases associated with overall natural improvements in healthcare and based on the data sets were unable to “differentiate between incidence, prevalence and mortality.”

Click to read the study in International Journal of Public Health

RELATED REPORTS

Human papillomavirus (HPV) vaccination rates have increased in recent years

Human papillomavirus vaccine effective in preventing infections in the United States

Unsweetened coffee consumption is associated with reduced risk of mortality

Relevant Reading: Post-1950 mortality trends and medical care: gains in life expectancy due to declines in mortality from conditions amenable to medical intervention in The Netherlands

In-Depth [retrospective literature study]: This study used data from Estonia, Spain, West Germany, The Netherlands, France, Sweden, and the UK to compare trends across national boundaries. For each cancer, researchers identified a specific intervention or therapeutic development and a range of time wherein that intervention was introduced to patients. The interventions identified for each cancer are the following:

Breast Cancer – mammographic screening and treatment with Tamoxifen

Cervical Cancer – Cervical screening

Testicular Cancer – Cisplatin treatment

Hodgkin’s Disease – High-dose therapy combined with peripheral blood stem cell transplantation

Leukemia – Overall improved treatment of disease process and complications

Researchers were looking specifically at the timing of the introduction of the therapies and how their introduction impacted mortality trends favorably. In each cancer there was an insignificant change in the mortality trend after introduction: breast cancer (p=.364), cervical cancer (p=.254), testicular cancer (p=.488), Hodgkin’s disease (p=.384), and leukemia (p=.396). The authors of the study were quick to comment that these results are not a reflection of the effectiveness of the treatment, but rather a look at how the introduction of the treatment impacted mortality in a positive manner.

By Jordan Anderson and Andrew Bishara

More from this author: Slowdown in healthcare costs linked to economic and clinical factors; Economic incentives alter nutritional patterns in South Africa; Emerging coronavirus found to spread in healthcare facilities; CT scans linked to cancer risk in children; Slowdown in healthcare costs linked to economic and clinical factors;

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: Breast Cancercervical cancerhodgkin'sleukemiamortalitypreventiontesticular caner
Previous Post

Rituximab linked with reduced chronic immune disease following stem cell transplantation

Next Post

Racial backgrounds key to shaping the face of smoking-related mortality in South Africa

RelatedReports

Mental health parity law associated with financial protection for children
Chronic Disease

Human papillomavirus (HPV) vaccination rates have increased in recent years

June 23, 2022
Reduced doses of human papillomavirus vaccine may be effective in preventing condyloma
Public Health

Human papillomavirus vaccine effective in preventing infections in the United States

June 23, 2022
European data showed coffee consumption associated with lower mortality
Cardiology

Unsweetened coffee consumption is associated with reduced risk of mortality

June 21, 2022
Reduced HPV vaccine doses may be adequate
Infectious Disease

Human Papillomavirus self-sampling may be a culturally-sensitive alternative for Muslim women

June 20, 2022
Next Post
Smokeless tobacco use in children has not changed

Racial backgrounds key to shaping the face of smoking-related mortality in South Africa

Classics Series, Landmark Trials in Medicine

Clinical decision rule associated with 40% decrease in ALTE-related hospital admissions [Classics Series]

Among HIV-positive infants, early protease inhibitor-based treatment effective

Among HIV-positive infants, early protease inhibitor-based treatment effective

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
  • The RAPTURE trial: Radiofrequency ablation effective and safe in lung cancer [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.